Evidence map›Paper›PMID 41452415›Full record

ArticleApplied biochemistry and biotechnology2026

Synthesis of 4-hydroxybenzoic Acid in Escherichia coli by a Modular co-culture System.

Yang Zhao, Xiaomei Xu, Shuo Zhao, Pengfei Gu

Abstract read
PubMed Publisher
In one paragraph

Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yang Zhao *School of Biological Science and Technology, University of Jinan, Jinan, 250022, People's Republic of China.
Xiaomei Xu *School of Biological Science and Technology, University of Jinan, Jinan, 250022, People's Republic of China.
Shuo Zhao *School of Biological Science and Technology, University of Jinan, Jinan, 250022, People's Republic of China.
Pengfei GuSchool of Biological Science and Technology, University of Jinan, Jinan, 250022, People's Republic of China. bio_gupf@ujn.edu.cn.ORCID http://orcid.org/0000-0001-9275-9636

Funding

the Key R&D Program of Shandong Province, China 2022SFGC0102the National Natural Science Foundation of China 32270093
6 · The paper itself

Abstract

Advancements in metabolic engineering and synthetic biology have enabled microbial production of an extensive range of valuable chemicals. Traditionally, a single microbial strain is used in these processes. However, the integration of complex, multi-layered regulatory mechanisms within metabolic pathways imposes a significant metabolic burden on host cells. To address these challenges, modular co-culture strategies have garnered increasing attention. In this study, we constructed a modular co-culture system to produce 4-hydroxybenzoic acid (4-HBA), which has applications across diverse fields, including food, medicine, and cosmetics. The complete 4-HBA synthesis pathway was segmented into upstream and downstream modules at the shikimic acid node, with each module constructed in separate Escherichia coli strains. During modular co-culture of the upstream and downstream strains, the maximum production titer of 4-HBA reached 0.928 g/L when the initial inoculation ratio of upstream to downstream strains was 2:1. This study represents the first report of 4-HBA synthesis using glucose as the sole carbon source through modular co-culture technology, thereby expanding the application scope of this technology and providing a valuable reference for microbial production of 4-HBA.

Indexed as

Escherichia coliParabensCoculture TechniquesGlucoseMetabolic Engineering4-hydroxybenzoic acidGlucoseParabens4-Hydroxybenzoic acidMetabolic pathwayMicrobial synthesisModular co-culture

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.